Table 3.
Indication | n | Fibroid cases% (N=90) | Controls %a(N=111) |
---|---|---|---|
Pain | |||
Pelvic | 15 | 70 | 4 |
Abdominal | 27 | 20 | 82 |
Other | 6 | 10 | 14 |
Bleeding | |||
Postmenopausal | 8 | 21 | 25 |
Dysmenorrhea | 4 | 11 | 13 |
Menorrhagia | 19 | 57 | 38 |
Oligomenorrhea | 3 | 11 | 25 |
Reproductive | |||
Normal pregnancy | 28 | 100 | 63 |
Pregnancy complication | 13 | 0 | 32 |
Bleeding during pregnancy | 1 | 0 | 2 |
Other | 1 | 0 | 2 |
Malignancy | 5 | ||
Suspected malignancy | 1 | 0 | 33 |
Known malignancy | 4 | 100 | 67 |
A portion of women were missing indications for pelvic imaging due to incomplete information in their records.
Summarized data are for the first pelvic imaging procedure for controls.